DUBLIN--(BUSINESS WIRE)--The "Global Vaccines Market 2022-2032" report has been added to ResearchAndMarkets.com's offering.
This recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics.
After conducting thorough research on the historical and current growth parameters of the Vaccines Market, the growth prospects of the market are obtained with maximum precision.
Companies Mentioned
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Pfizer
- Sanofi Sa
- Csl Limited
- Emergent Biosolutions Inc.
- Johnson & Johnson (J&J)
- Astrazeneca
- Bavarian Nordic A/S
- Mitsubishi Tanabe Pharma Corporation
Key Topics Covered:
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Vaccines Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Vaccines Market By Country, US$ Mn
4.2. Vaccines Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Vaccines Market Growth
4.5.3. Vaccines Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Vaccines Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Vaccines Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Vaccines Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
8.1. Introduction/Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032
8.3.1. Conjugate Vaccines
8.3.2. Inactivated & Subunit Vaccines
8.3.3. Live Attenuated Vaccines
8.3.4. Recombinant Vaccines
8.3.5. Toxoid Vaccines
8.3.6. Viral Vector Vaccines
8.4. Market Attractiveness Analysis By Technology
9. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Type
9.1. Introduction/Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Type, 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Type, 2022-2032
9.3.1. Monovalent Vaccines
9.3.2. Multivalent Vaccines
9.4. Market Attractiveness Analysis By Type
10. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration
10.1. Introduction/Key Findings
10.2. Historical Market Value (US$ Mn) and Analysis By Route of Administration, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Route of Administration, 2022-2032
10.3.1. Intramuscular & Subcutaneous Administration
10.3.2. Oral Administration
10.3.3. Other Routes of Administration (Intranasal, Intradermal, and Percutaneous)
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication
11.1. Introduction/Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Disease Indication, 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Disease Indication, 2022-2032
11.3.1. Influenza
11.3.2. Pneumococcal Diseases
11.3.3. Combination Vaccines
11.3.4. HPV
11.3.5. Herpes Zoster
11.3.6. Meningococcal Diseases
11.3.7. Rotavirus
11.3.8. MMR
11.3.9. Varicella
11.3.10. Hepatitis
11.3.11. DTP
11.3.12. Polio
11.3.13. COVID 19
11.3.14. Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)
11.4. Market Attractiveness Analysis By Disease Indication
12. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By End-user
12.1. Introduction/Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By End-user, 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By End-user, 2022-2032
12.3.1. Pediatric Vaccines
12.3.2. Adult Vaccines
12.4. Market Attractiveness Analysis By End-user
13. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Region
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
For more information about this report visit https://www.researchandmarkets.com/r/c647ml
